ZL-82 / Baoling Bio - LARVOL DELTA

A Phase II Clinical Study Evaluating of ZL-82 Tablets in Atopic Dermatitis (clinicaltrials.gov) - P2 | N=111 | Not yet recruiting | Sponsor: Chengdu Zenitar Biomedical Technology Co., Ltd

New P2 trial • Atopic Dermatitis • Dermatitis • Dermatology • Immunology

ZL-82 Double-blind Clinical Trial (clinicaltrials.gov) - P1 | N=41 | Completed | Sponsor: Chengdu Zenitar Biomedical Technology Co., Ltd | Recruiting ➔ Completed

Trial completion

A randomized, double-blind, placebo-controlled, parallel-group phase II clinical study to evaluate the efficacy and safety of ZL-82 tablets in participants with moderate to severe atopic dermatitis (ChiCTR) - P2 | N=111 | Not yet recruiting | Sponsor: West China Hospital of Sichuan University; Chengdu Zenitar Biomedical Technology Co., Ltd.

New P2 trial • Atopic Dermatitis • Dermatitis • Dermatology • Immunology

A single-center, randomized, double-blind, placebo-controlled, dose-escalation study of the safety, tolerability, pharmacokinetics, pharmacodynamics and QTc effect of single and multiple oral doses of ZL-82 tablet in healthy Chinese subjects. (ChiCTR) - P1 | N=40 | Completed | Sponsor: PKUCare Luzhong Hospital; Chengdu Zenitar Biomedical Technology Co., Ltd.

New P1 trial • Atopic Dermatitis • Dermatitis • Dermatology • Gastroenterology • Gastrointestinal Disorder • Immunology • Inflammatory Arthritis • Inflammatory Bowel Disease • Rheumatoid Arthritis • Rheumatology • Ulcerative Colitis • STAT5

Phase I Clinical Study of ZL-82 Tablets (clinicaltrials.gov) - P1 | N=69 | Completed | Sponsor: Chengdu Zenitar Biomedical Technology Co., Ltd | Recruiting ➔ Completed | Trial completion date: Dec 2024 ➔ Jun 2024

Trial completion • Trial completion date • Gastroenterology • Gastrointestinal Disorder • Immunology • Inflammation • Inflammatory Arthritis • Inflammatory Bowel Disease • Rheumatoid Arthritis • Rheumatology

ZL-82 Double-blind Clinical Trial (clinicaltrials.gov) - P1 | N=40 | Recruiting | Sponsor: Chengdu Zenitar Biomedical Technology Co., Ltd

New P1 trial

Study of Tolerability, Safety, and Pharmacokinetics of ZL-82 in Healthy Adult Subjects. (clinicaltrials.gov) - P1 | N=58 | Recruiting | Sponsor: Chengdu Zenitar Biomedical Technology Co., Ltd

New P1 trial • Gastroenterology • Gastrointestinal Disorder • Immunology • Inflammation • Inflammatory Arthritis • Inflammatory Bowel Disease • Rheumatoid Arthritis • Rheumatology